FDA Advisers Agree Maternal RSV Vaccine Protects Infants, but Are Divided on Its Safety

Troubled by side effect data from Pfizer’s trials and by another big drugmaker’s abandonment of a similar vaccine given during pregnancy, the panel split on the question of the vaccine’s safety, with multiple members concerned that it may increase the rate of premature births.